ASPM and ovarian cancer: ASPM is aberrantly expressed in various tumors, such as glioblastoma (41), endometrial adenocarcinoma (42), pancreatic cancer (43), prostate adenocarcinoma (44), and ovarian cancer (45, 46), and is associated with tumor prognosis.